证券代码：002209 证券简称：达意隆 公告编号：2025-025 广州达意隆包装机械股份有限公司 关于股票交易异常波动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 3、公司近期生产经营情况正常，内外部经营环境未发生重大变化； 4、公司、控股股东和实际控制人不存在关于公司的应披露而未披露的重大 事项或处于筹划阶段的重大事项； 5、在公司本次股票异常波动期间，不存在控股股东、实际控制人买卖公司 股票的情况。 三、不存在应披露而未披露信息的说明 公司董事会确认，公司目前没有任何根据《深圳证券交易所股票上市规则》 等有关规定应予以披露而未披露的事项或与该事项有关的筹划、商谈、意向、协 议等；董事会也未获悉公司有根据《深圳证券交易所股票上市规则》等有关规定 应予以披露而未披露的、对公司股票及其衍生品种交易价格产生较大影响的信息； 公司前期披露的信息不存在需要更正、补充之处。 广州达意隆包装机械股份有限公司（以下简称"公司"）的股票（证券简称： 达意隆，证券代码：002209）连续两个交易日内（2025 年 7 月 11 日、 ...

Performance Forecast - The company expects a net profit of 75 million to 100 million yuan for the current reporting period, compared to 28.58 million yuan in the same period last year, representing a growth of 162.38% to 249.84% [1] - The net profit after deducting non-recurring gains and losses is projected to be 74 million to 99 million yuan, up from 18.80 million yuan last year, indicating a growth of 293.61% to 426.58% [1] - Basic earnings per share are estimated to be between 0.3768 yuan and 0.5024 yuan, compared to 0.1436 yuan per share in the previous year [1] Communication with Auditor - The performance forecast data is based on preliminary calculations by the company's finance department and has not been audited by the accounting firm. Initial communication with the auditor indicates no significant discrepancies [1] Reasons for Performance Change - The main reasons for the performance change include the company's continuous efforts in market expansion, product structure optimization, and cost reduction measures, which have enhanced operational efficiency and competitiveness, leading to steady growth in revenue and profit [1]

Group 1 - Seli Medical's therapeutic hypertension vaccine project faces significant uncertainty despite recent market interest, with a 2024 revenue of 26,800 yuan and a net loss of 2,382,300 yuan [3] - Renfu Pharmaceutical's shareholder plans to increase their stake with a loan commitment of up to 750 million yuan, aiming to acquire 1% to 2% of the company's shares at a maximum price of 25.53 yuan per share [4] - China Northern Rare Earth's third-quarter trading price for rare earth concentrate is set at 19,109 yuan per ton, with price adjustments based on REO percentage changes [7][9] Group 2 - Saisir expects a net profit increase of 66.2% to 96.98% for the first half of 2025, driven by new product launches and improved sales [13] - WuXi AppTec anticipates a 44.43% increase in adjusted net profit for the first half of 2025, with revenue expected to reach approximately 20.799 billion yuan [15] - Yiyuan Communication forecasts a 121.13% increase in net profit for the first half of 2025, capitalizing on the growth of 5G and AI technologies [16] Group 3 - Longqing Co. expects a net profit increase of 106.02% to 131.77% for the first half of 2025, attributed to production capacity release and cost reduction [17] - Guosheng Financial Holdings predicts a net profit increase of 236.85% to 394.05% for the first half of 2025, supported by improved brokerage and investment banking performance [18] - Dali Long anticipates a net profit increase of 162.38% to 249.84% for the first half of 2025, driven by market expansion and operational efficiency [19] Group 4 - Tianbao Infrastructure expects a staggering net profit increase of 1581.8% to 2329.27% for the first half of 2025, largely due to a significant tax refund [20] - China Shipbuilding anticipates a net profit increase of 98.25% to 119.49% for the first half of 2025, benefiting from improved production efficiency and order structure [21] - Shanghai Xiba expects a net profit increase of 136.47% to 181.85% for the first half of 2025, influenced by non-recurring income [22] Group 5 - *ST Yanzhen reports a total of 53.773 million shares accepted in a tender offer, representing 20.47% of total equity, with a new major shareholder emerging [12] - Shanghai Mechanical and Electrical's major shareholder has received approval for a share transfer that will not change the company's control [10] - Good Products plans to suspend trading due to a potential change in control, with a suspension expected for no more than two trading days [11]

证券代码：002209 证券简称：达意隆 公告编号：2025-024 广州达意隆包装机械股份有限公司 2025年半年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 6 月 30 日 2、业绩预告情况：□扭亏为盈 ■同向上升 □同向下降 | 项目 | 本报告期 | 上年同期 | | --- | --- | --- | | 归属于上市公司股 东的净利润 | 盈利：7,500万元–10,000万元 | 盈利：2,858.48万元 | | | 比上年同期增长：162.38%–249.84% | | | 扣除非经常性损益 后的净利润 | 盈利：7,400万元–9,900万元 | 盈利：1,880.04万元 | | | 比上年同期增长：293.61%–426.58% | | | 基本每股收益 | 盈利：0.3768元/股–0.5024元/股 | 盈利：0.1436元/股 | 二、与会计师事务所沟通情况 本次业绩预告的相关数据是公司财务部门初步测算的结果，未经会计师事务 所审计 ...

达意隆（002209）公告，预计2025年1月1日至2025年6月30日归属于上市公司股东的净利润为7500万元– 1亿元，比上年同期的2858.48万元增长162.38%–249.84%。扣除非经常性损益后的净利润为7400万元– 9900万元，比上年同期的1880.04万元增长293.61%–426.58%。基本每股收益为0.3768元/股–0.5024元/ 股。 ...

Core Viewpoint - Dali Long (002209) has signed a new contract with Jiangsu Shangshou Biotechnology Co., Ltd. for a 48,000 BPH embryo chemical dry sterilization line, following a previous contract for a 24,000 BPH line in January 2024. The company's technology significantly reduces packaging sterilization energy consumption by over 80% compared to traditional wet methods [1] Summary by Category Company Developments - Dali Long has secured a contract for a 48,000 BPH embryo chemical dry sterilization line with Jiangsu Shangshou Biotechnology Co., Ltd. [1] - This follows an earlier agreement in January 2024 for a 24,000 BPH line, indicating a growing partnership and demand for Dali Long's technology [1] Industry Impact - The introduction of Dali Long's embryo chemical dry sterilization line represents a significant advancement in sterilization technology, reducing energy consumption by over 80% compared to traditional methods [1]

Group 1 - The legal opinion is regarding the second unlock period of the restricted stock incentive plan for Guangzhou Dayilong Packaging Machinery Co., Ltd. [1][15] - The company has obtained necessary approvals and authorizations for the second unlock period of the restricted stock incentive plan, which complies with relevant laws and regulations [15] - The conditions for unlocking the restricted stocks have been met, allowing for the release of 30% of the total restricted stocks granted [10][15] Group 2 - The first grant date for the restricted stocks was established as June 14, 2023, with the second unlock period set to expire on July 10, 2025 [10][8] - The performance target for the incentive plan requires a net profit of no less than 30 million yuan, which has been exceeded with a reported net profit of approximately 77.78 million yuan for 2024 [13][11] - A total of 23 individuals are involved in this unlock process, and they have been verified to meet the necessary conditions for unlocking their restricted stocks [12][14] Group 3 - The company has committed to timely disclose relevant documents and continue fulfilling its information disclosure obligations as the incentive plan progresses [14][15] - The legal opinion confirms that the company has adhered to the necessary legal standards and ethical norms in the issuance of this opinion [4][15] - The company will handle the registration procedures for the unlocking of the restricted stocks in accordance with applicable regulations [15]

Core Viewpoint - The supervisory board of Guangzhou Dayilong Packaging Machinery Co., Ltd. has verified the list of individuals eligible for the second unlock period of the restricted stock incentive plan, confirming compliance with relevant laws and regulations [1][2]. Group 1: Compliance with Regulations - The company meets the conditions set forth in the "Incentive Plan (Draft)" and relevant laws for implementing the stock incentive plan, confirming its eligibility to execute the plan [1]. - The supervisory board has determined that the incentive objects do not fall under any disqualifying conditions outlined in the regulations, such as being deemed inappropriate candidates by the stock exchange or the China Securities Regulatory Commission (CSRC) within the last 12 months [1][2]. Group 2: Eligibility of Incentive Objects - The individuals eligible for the second unlock period possess the qualifications required by the Company Law and other relevant regulations, and they are all current employees with formal labor or employment relationships with the company [2]. - The incentive plan excludes independent directors, supervisors, and shareholders or actual controllers holding 5% or more of the company's shares, along with their immediate family members [2].

广州达意隆包装机械股份有限公司 关于2023年限制性股票激励计划首次授予部分第二个解除 限售期解除限售条件成就的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 1、公司 2023 年限制性股票激励计划首次授予部分第二个解除限售期解除限 售条件已经成就，符合解除限售条件的激励对象共计 23 名，可解除限售的限制 性股票数量为 105.15 万股，占公司当前总股本的 0.53%。 证券代码：002209 证券简称：达意隆 公告编号：2025-023 2、本次限制性股票解除限售尚需在相关部门办理解除限售手续，在上市流 通前，公司将发布相关提示性公告，敬请投资者注意。 广州达意隆包装机械股份有限公司（以下简称"公司"）于 2025 年 7 月 1 日召开第九届董事会第五次会议、第七届监事会第四次会议，审议通过《关于 2023 年限制性股票激励计划首次授予部分第二个解除限售期解除限售条件成就 的议案》。根据《上市公司股权激励管理办法》（以下简称《管理办法》）《广 州达意隆包装机械股份有限公司 2023 年限制性股票激励计划（草案）》（以下 简称《激 ...

广州市天河区珠江新城珠江西路 21 号 粤海金融中心 28 层 邮编：510627 电话：（86-20）2805-9088 传真：（86-20）2805-9099 北京市君合（广州）律师事务所 关于 广州达意隆包装机械股份有限公司 2023 年限制性股票激励计划 要查阅的文件以及本所经办律师认为必须查阅的其他文件。公司保证：其已经及时提 供了出具本法律意见书所必需的所有的书面材料或口头说明，公司所提供的全部书面 材料、口头说明或通过即时通讯工具与本所的沟通及其所述之内容及信息均是真实、 准确、完整和有效的，不存在任何隐瞒、虚假记载、误导性陈述或重大遗漏之处；其中 所提供的复印件、扫描件或照片与原件或原物完全一致；公司所提供的所有书面材料 中，已签署文件的各方均依法存续并取得了适当的授权签署该等文件，文件上的签名 和/或印章均是真实的；各文件的原件的效力在其有效期内均未被有关政府部门撤销， 且于本法律意见书出具之日均由其各自的合法持有人持有；公司相关人员所有口头陈 述和说明、与本所即时通讯沟通的内容和信息均与所发生的事实一致。 本所及经办律师依据《证券法》《律师事务所从事证券法律业务管理办法》和《律 师事务所证 ...